Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite improvements in operating expenses and a reduced operating loss, the increase in net loss due to foreign exchange fluctuations and reduced R&D spending pose concerns. The lack of shareholder return discussion and unclear management responses in the Q&A further contribute to uncertainty. These mixed signals suggest a neutral sentiment for the stock price in the short term.
Operating Expenses USD 682,000, representing an 11% decrease compared to the first quarter of 2025. The reduction was primarily driven by lower research and development, sales and marketing, and general and administrative expenses.
Research and Development Expenses USD 140,000 compared to USD 181,000 during the same period last year, showing a decrease.
Sales and Marketing Expenses USD 71,000 compared to USD 77,000 in the prior year period, showing a decrease.
General and Administrative Expenses USD 499,000 from USD 539,000 last year, showing a decrease.
Operating Loss USD 682,000 compared to USD 765,000 during the same period in 2025, showing an improvement year-over-year.
Other Income USD 52,000 compared to USD 54,000 during the same period last year, remaining relatively stable and primarily driven from technology demonstration activity as well as management fees from a joint venture.
Net Loss USD 695,000 compared to approximately USD 505,000 during the same period last year. The change was primarily attributable to foreign exchange fluctuation, including the appreciation.
Operating Expenses: Operating expenses for Q1 2026 were approximately USD 682,000, an 11% decrease compared to Q1 2025, driven by reductions in R&D, sales and marketing, and general and administrative expenses.
Research and Development Expenses: R&D expenses decreased to approximately USD 140,000 compared to USD 181,000 in Q1 2025.
Sales and Marketing Expenses: Sales and marketing expenses were approximately USD 71,000 compared to USD 77,000 in Q1 2025.
General and Administrative Expenses: General and administrative expenses decreased to approximately USD 499,000 from USD 539,000 in Q1 2025.
Operating Loss: Operating loss improved year-over-year, decreasing to approximately USD 682,000 compared to USD 765,000 in Q1 2025.
Net Loss Increase: Net loss for the quarter increased to approximately USD 695,000 compared to USD 505,000 during the same period last year, primarily due to foreign exchange fluctuations.
Foreign Exchange Fluctuations: The appreciation of foreign currencies negatively impacted financial results, contributing to the increased net loss.
Reduced R&D Spending: Research and development expenses decreased, which could potentially slow innovation and technological advancements critical for the company's growth.
Operating Expenses: Operating expenses for the quarter were approximately USD 682,000, representing an 11% decrease compared to the first quarter of 2025. The reduction was primarily driven by lower research and development, sales and marketing and general and administrative expenses.
Research and Development Expenses: Research and development expenses decreased to approximately USD 140,000 compared to USD 181,000 during the same period last year.
Sales and Marketing Expenses: Sales and marketing expenses were approximately USD 71,000 compared to USD 77,000 in the prior year period.
General and Administrative Expenses: General and administrative expenses decreased to approximately USD 499,000 from USD 539,000 last year.
Operating Loss: Operating loss improved year-over-year, decreasing to approximately USD 682,000 compared to USD 765,000 during the same period in 2025.
Other Income: Other income remained relatively stable at approximately USD 52,000 compared to USD 54,000 during the same period last year and was primarily driven from technology demonstration activity as well as management fees for -- from a joint venture.
Net Loss: Net loss for the quarter was approximately USD 695,000 compared to approximately USD 505,000 during the same period last year. The change was primarily attributable to foreign exchange fluctuation, including the appreciation.
The selected topic was not discussed during the call.
Despite improvements in operating expenses and a reduced operating loss, the increase in net loss due to foreign exchange fluctuations and reduced R&D spending pose concerns. The lack of shareholder return discussion and unclear management responses in the Q&A further contribute to uncertainty. These mixed signals suggest a neutral sentiment for the stock price in the short term.
The earnings call presents a mixed picture: while there are positive developments in project execution and strategic partnerships, the increase in operating expenses, net loss, and regulatory challenges pose significant risks. The Q&A section did not provide additional clarity on these issues, leaving uncertainties unresolved. The company's global expansion efforts and technological advancements are promising, but financial strains and potential delays in project timelines temper optimism. Given these factors, the stock price reaction over the next two weeks is likely to be neutral, with no significant catalysts to drive a strong positive or negative movement.
The earnings call summary presents mixed signals: positive project developments and partnerships, but ongoing net losses and increased operating expenses. The Q&A section didn't provide additional insights, as no questions were asked. While new partnerships and project expansions are promising, the financial position shows slight improvements but remains challenged. Given the absence of strong positive catalysts or concerning negative trends, and considering the lack of market cap information, a neutral stock price movement is expected over the next two weeks.
The earnings call revealed mixed signals: while there are positive developments like reduced expenses, partnerships in Asia, and a share repurchase program, the increased net loss and lack of clear guidance on revenue growth or profitability are concerning. The Q&A highlighted management's uncertainty about future financials, which may temper investor enthusiasm. Despite the positive outlook for 2025, the immediate financial challenges and competitive pressures suggest a neutral stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.